Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Expanded Access to Tavapadon
- Status
- AVAILABLE
- Phase
- N/A
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
- Status
- RECRUITING
- Phase
- N/A
Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China
- Status
- COMPLETED
- Phase
- N/A
Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India
- Status
- RECRUITING
- Phase
- PHASE4